# The Evaluation of Safety and Tolerance of Commercially Available Naltrexone Administered Daily - Assessment for CBRN Operations

> **NCT03879460** · PHASE1 · COMPLETED · sponsor: **Timothy Smith** · enrollment: 15 (actual)

## Conditions studied

- Opioid Intoxication

## Interventions

- **DRUG:** Naltrexone Hydrochloride

## Key facts

- **NCT ID:** NCT03879460
- **Lead sponsor:** Timothy Smith
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-18
- **Primary completion:** 2019-03-31
- **Final completion:** 2019-03-31
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2019-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03879460

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03879460, "The Evaluation of Safety and Tolerance of Commercially Available Naltrexone Administered Daily - Assessment for CBRN Operations". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03879460. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*